ClinicalTrials.gov
ClinicalTrials.gov Menu

CEA-Expressing Liver Metastases Safety Study of Intrahepatic Infusions of Anti-CEA Designer T Cells (HITM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01373047
Recruitment Status : Completed
First Posted : June 14, 2011
Last Update Posted : July 30, 2013
Sponsor:
Information provided by (Responsible Party):
Roger Williams Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2013
  Actual Study Completion Date : July 2013